Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.8520
+0.0070 (0.83%)
At close: May 9, 2025, 4:00 PM
0.8983
+0.0463 (5.43%)
After-hours: May 9, 2025, 4:50 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $60.96 million as of May 9, 2025. Its market cap has decreased by -16.77% in one year.
Market Cap
60.96M
Enterprise Value
64.76M
1-Year Change
-16.77%
Ranking
Category
Stock Price
0.85
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $60.96M, a decrease of -32.42%. That is a compound annual growth rate of -14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 60.96M | -25.91% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 350.94B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |